TrialMedicine2016

Infliximab therapy for intestinal, neurological, and vascular involvement in Behcet disease: Efficacy, safety, and pharmacokinetics in a multicenter, prospective, open-label, single-arm phase 3 study.

Toshifumi Hibi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.